In recent years, the rise in medical costs has become a critical issue across Asia. To understand the impact of medical inflation on insurance companies, we have conducted a survey amongst life and health insurers across seven Asian regions, representing 59 companies. In this Asia e-Alert, we discuss: 

• The definition of medical inflation
• Current and future outlook on medical inflation
• How often did insurers reprice their medical and health (M&H) business?
• Future repricing expectations
• Frequent repricing to address increasing claim costs
• Key drivers to increasing claim costs
• Valuation of M&H business